Ny Sin
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Chemical Synthesis and Analysis
- Glycosylation and Glycoproteins Research
Papers in
-
- Carbohydrate Chemistry and Synthesis 3
-
- Ubiquitin and proteasome pathways 4
- Co-authors
- Craig M. Crews (7 shared papers)Lihao Meng (5 shared papers)Benjamin H. Kwok (3 shared papers)Mikael Elofsson (2 shared papers)Royce Mohan (1 shared paper)James Wen (1 shared paper)William G. Bornmann (1 shared paper)Kyung Bo Kim (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Proceedings of the National Academy of Sciences (2 papers)Tetrahedron Letters (2 papers)Magnetic Resonance in Chemistry (1 paper)Microchemical Journal (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Ny Sin
19 papers receiving 1.9k citations
Ny Sin's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 703
- Molecular Biology 1.4k
- Cancer Research 201
- Cell Biology 188
- Hematology 107
Countries citing papers authored by Ny Sin
This map shows the geographic impact of Ny Sin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ny Sin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ny Sin more than expected).
Fields of papers citing papers by Ny Sin
This network shows the impact of papers produced by Ny Sin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ny Sin. The network helps show where Ny Sin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ny Sin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity Hit paper breakdown → | 1999 | 802 |
| 2 | The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2 Hit paper breakdown → | 1997 | 533 |
| 3 | 1999 | 163 | |
| 4 | Eponemycin exerts its antitumor effect through the inhibition of proteasome function. | 1999 | 132 |
| 5 | 1999 | 103 | |
| 6 | 2004 | 58 | |
| 7 | 1998 | 50 | |
| 8 | 2009 | 36 | |
| 9 | 1998 | 31 | |
| 10 | 2016 | 26 | |
| 11 | 2018 | 18 | |
| 12 | 1993 | 16 | |
| 13 | 1996 | 15 | |
| 14 | 2009 | 14 | |
| 15 | 2010 | 4 | |
| 16 | 1990 | 4 | |
| 17 | 1989 | 3 | |
| 18 | 1997 | 2 | |
| 19 | 2021 | 1 | |
| 20 | 2024 | 0 |
About Ny Sin
Ny Sin is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Infectious Diseases and Cancer Research, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (4 papers), HIV/AIDS drug development and treatment (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), HIV Research and Treatment (3 papers), Virology and Viral Diseases (2 papers), Electron Spin Resonance Studies (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Oncology (703 citations), Molecular Biology (1.4k citations), Cancer Research (201 citations), Cell Biology (188 citations) and Hematology (107 citations). Ny Sin has collaborated with scholars based in United States and Germany. Frequent co-authors include Craig M. Crews, Lihao Meng, Benjamin H. Kwok, Mikael Elofsson, Royce Mohan, James Wen, William G. Bornmann, Kyung Bo Kim, Lin Meng and Jayhyuk Myung. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences, Tetrahedron Letters, Magnetic Resonance in Chemistry and Microchemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.